ZeroCarbFP Strategic Alliance Given Go-Ahead After Successful Interim Review

Alliance's second phase commenced on 1 October 2016

Zwingenberg, (PresseBox) - The ZeroCarbFP Strategic Alliance was the third research alliance funded under the German Ministry of Education and Research’s “Innovation Initiative for Industrial Biotechnology” programme, starting to work on 1 July 2013. Following nearly three years of successful research and development, the alliance had to undergo a scientific interim review by a panel of experts set up by the Ministry of Education and Research in early 2016.

The expert panel green-lighted the continuation of the funding arrangements for the ZeroCarbFP Strategic Alliance during the second phase, which started on 1 October 2016 and is scheduled to end on 30 September 2019. BRAIN AG (ISIN DE0005203947 / WKN 520394), the bioeconomy company, acts as coordinator during the second phase of funding, taking over that role from Emschergenossenschaft. Another three-year period, known as Phase 3, is planned and will be presented to the expert panel for another interim evaluation in early 2019.

A total of nine alliance representatives and coordinators from Emschergenossenschaft took the questions from the expert panel. The group provided insights into the past three years of joint research efforts, while they also answered the experts’ questions on the plans for the second phase of the ZeroCarb programme and presented new partners.

By using biotechnology, the ZeroCarbFP alliance seeks to establish the industrial research, development and production of ‘functional biomass’ through the use of materials provided by carbonaceous waste streams. The alliance thus works in an area where breakthrough innovative ideas are pushed for by politicians as well as the economy and the society so that more arable land can be retained to grow food crops.

The past three years were used by researchers to focus on identifying enzymes / biocatalysts and microorganisms that help utilise and transform waste streams into sources of raw materials. So far, several processes have been evaluated on a laboratory scale and some first synergies became apparent in the shape of a bio-refinery project.

During the following two ZeroCarbFP stages, the development and pilot phases, the alliance partners will now work to bring the bio-procedures identified so far to market maturity, with the full value-added chain in mind. The first ZeroCarbFP phase saw the publication of four scientific papers, numerous lectures at symposia, six press releases as well as some patent applications for letters patent (two plus two in the pipeline), all of which highlight the extraordinary quality of what has been achieved so far in both the scientific and economic arenas.

First pre-production samples, which were generated and made available for application testing, round off the successful endeavours undertaken by the alliance. The results delivered in Phase 1 and the projects planned for Phase 2 were likewise appreciated by the expert panel. During Phase 2, researchers will now focus on the development of the required process parameters through translating initial Phase 1 processes into a pilot environment.

“Phase 1 results have exceeded our expectations in many respects. After such a short period of research and development it is really impressive to see how very promising some first products perform in application tests. I’d like to pay a big compliment to everybody involved in the alliance,” says Dr Jürgen Eck, CEO of BRAIN AG.

As the second phase commences, BRAIN AG takes over the role of alliance coordinator of from Emschergenossenschaft. This change was unanimously approved by all alliance partners.

“We are delighted all ZeroCarb alliance partners have chosen us to take over the role as coordinators from Emschergenossenschaft and we wish to thank everybody for the trust placed in us. Due to the planned shift in emphasis to process development, the alliance now includes a larger number of industrial partners specialising in process engineering and pilot testing. We expect them to strengthen the alliance in terms of process establishment and engineering and they will also help us gain better market access and will contribute their excellent marketing skills,“ states Dr Guido Meurer, Executive Vice President and head of the ZeroCarb coordination team at BRAIN.

With effect from 1 October 2016 and coinciding with the start of the second (or development) phase of ZeroCarbFP, the Phase 1 line-up including, among others, Bioeton Germany, BRAIN, Fuchs Schmierstoffe and Südzucker was complemented by EMERY Oleochemicals as new industrial partners and Cronimet Mining AG as associated industrial partners. Under the umbrella of ZeroCarbFP industrial companies work hand in glove with numerous partners from academia to advance the alliance’s R&D efforts.

About ZeroCarbFP

The ZeroCarbFP strategic alliance currently unites 18 industrial, SME and academic partners. The alliance, which has the funding code FKZ 031A206, is scheduled to last for nine years and has a total budget of Euro 48m at its disposal. After winning the bid, the alliance was the third strategic alliance to be co-funded from 1 July 2013 under the German Ministry of Education and Research’s “Innovation Initiative for Industrial Biotechnology” programme. The alliance’s Phase 2 efforts are coordinated by BRAIN AG of Zwingenberg. Phase 2, the development phase of the alliance, will last for three years and began on 1 October 2016.


BRAIN AG is one of Europe's leading technology companies in the field of industrial biotechnology, the core discipline of the bioeconomy. As such, BRAIN identifies previously untapped, efficient enzymes, microbial producer organisms or natural substances from complex biological systems that can be put to industrial use. The innovative solutions and products developed by means of this "Toolbox of Nature" are successfully applied in the chemistry, cosmetics and food industries. Today, BRAIN's business model is based on two pillars - "BioScience" and "BioIndustrial". The first pillar, "BioScience", comprises its - frequently exclusive - collaboration business with industrial partners such as BASF, Ciba, Clariant, Evonik, DSM, Genencor, Henkel, Nutrinova, RWE, Sandoz, Schering, Südzucker and Symrise to mention just a few. The second pillar, "BioIndustrial", comprises the development and commercialisation of BRAIN's own products and active product components. In FY 2014-5 the group generated a total output of ca Euro 25.7m and employed about 220 persons.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.